Alzheimer’s disease: Modeling current and potential targets
By the time we are 65, one in ten of us will have Alzheimer’s disease. This rises to fifty percent ...
News
By the time we are 65, one in ten of us will have Alzheimer’s disease. This rises to fifty percent ...
The importance of understanding protein-protein and protein-ligand interactions in immuno-oncology Immuno-oncology represents a new paradigm in the fight against cancer and ...
Historical context and significance Despite cancer being a disease that has been with us for centuries, it has never been ...
The old problem and the new paradigm Classical small molecule drug paradigms generally involve intervention at a ligand protein binding ...
I am delighted to announce that a new release of Cresset workflow components for the Pipeline Pilot™ environment is now available. These ...
A new release of workflow components for the KNIME™ environment is now available. This includes nodes for the Machine Learning ...
Electrostatic Complementarity (EC) is a popular method within Flare™, Cresset's comprehensive platform for ligand-based and structure-based drug design. The basic idea is ...
In this post I will describe how to instantiate a cluster on Google Cloud (or any other cloud platform supported by ElastiCluster) and ...
On 12th April 2019, the International Centre for Genetic Engineering and Biotechnology, New Delhi, India, hosted the symposium ‘Innovative Software for ...
Talking to a group of medicinal chemists at a conference over lunch raised the following question: “It’s really interesting to see ...
The release of Flare V2 brings quicker analysis of new design ideas and more automation of workflow processes. Andy Smith ...
We are pleased to announce the introduction of Flare Viewer, a free licensing option of Flare, our structure-based design application. ...